Key facts
- This page summarizes Paul J. Clancy's Form 4 filing for Xilio Therapeutics, Inc. (XLO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2025, 16:36.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The option was granted on June 11, 2025 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 11, 2026 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.
SEC remarks
Exhibit 24 - Power of Attorney